TerminatedPhase 3NCT03944512

Pravastatin to Prevent Preeclampsia

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The George Washington University Biostatistics Center
Principal Investigator
Maged Costantine, MD
Ohio State University
Intervention
Pravastatin(drug)
Enrollment
102 target
Eligibility
16 years · FEMALE
Timeline
20192024

Study locations (12)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03944512 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials